Ann Hepatobiliary Pancreat Surg.  2022 Aug;26(3):263-269. 10.14701/ahbps.21-169.

Epidemiological trends of gallbladder cancer in Australia between 1982 to 2018: A population-based study utilizing the Australian Cancer Database

Affiliations
  • 1Department of General Surgery, St. Vincent’s Hospital Melbourne, Melbourne, Australia
  • 2Department of Surgery, Austin Health, Melbourne, Australia
  • 3Department of Surgery, Swan Hill Hospital, Swan Hill, Australia
  • 4Department of Paediatrics, Monash University, Melbourne, Australia

Abstract

Backgrounds/Aims
Gallbladder cancer (GBC) is a rare neoplasm. The epidemiology of GBC has not been updated in Australia for over five decades.
Methods
Data of all Australian patients diagnosed with GBC at any age from 1982 to 2018 were identified from the Australian Cancer Database. Age-standardized rates were calculated and joinpoint analysis was performed to ascertain the trends of incidence and mortality of GBC.
Results
Between 1982 and 2018, there were 22,745 cases of GBC and 11,054 GBC-related deaths in Australia. There were three distinct periods showing changed incidence. Period 1 (1982–1995) was stable. Period 2 (1996–2006) showed reduced incidence in females (3.6 to 2.8/100,000; p < 0.01) and all Australians (3.7 to 2.8/100,000, p < 0.01). Period 3 (2006–2017) demonstrated significantly increased incidence in all groups (males: 2.7 to 4.0/100,000, p < 0.01; females: 2.8 to 3.5/100,000, p < 0.01; all Australians: 2.8 to 3.7/100,000, p < 0.01). Incidence between females and males had declined from 1.10 : 1 in 1982 to 0.87 : 1 in 2017. There was a 71% reduction in mortality (3.1 to 0.9/100,000; p < 0.01). Median age at diagnosis increased from 69.7 to 74.3 years for females and from 67.2 to 73.3 years for males. Increasing incidence in the 6th to 8th decade of life in males, compared to previous years, was noted.
Conclusions
Incidence, mortality, sex, and age of GBC have significantly changed in Australia since 1982. Rising incidence of GBC in Australia warrants further investigation.

Keyword

Australia; Epidemiology; Neoplasms; Incidence; Mortality

Figure

  • Fig. 1 Incidence of gallbladder cancer (GBC) in Australia per 100,000 population by decade. (A) 1980s (1982–1989), (B) 1990s (1990–1999), (C) 2000s (2000–2009), and (D) 2010s (2010–2017). Data for the Northern Territory were not recorded in the 1980s or 1990s.

  • Fig. 2 Age demographics for gallbladder cancer in Australia. (A) Median age at time of diagnosis by sex with linear regression; (B) Age distribution in 1982 and 2017 by sex and age distribution (per 100,000 population) at three points in our dataset (1982, 2000, and 2017) for (C) males and (D) females.

  • Fig. 3 Joinpoint regression analysis demonstrating three distinct periods showing changed Australian gallbladder cancer incidence (per 100,000 age-standardized population) separated by all Australians (A), females (B), and males (C).

  • Fig. 4 Australian gallbladder cancer mortality rate (per 100,000 age-standardized population) according to sex.


Reference

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. 2015; Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. DOI: 10.1002/ijc.29210. PMID: 25220842.
2. Bennett RC, Jepson RP. 1965; Carcinoma of the gall-bladder. Aust N Z J Surg. 34:278–283. DOI: 10.1111/j.1445-2197.1965.tb04375.x. PMID: 14296752.
3. Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC. 2015; Gallbladder cancer incidence and mortality, United States 1999-2011. Cancer Epidemiol Biomarkers Prev. 24:1319–1326. DOI: 10.1158/1055-9965.EPI-15-0199. PMID: 26070529.
4. Wi Y, Woo H, Won YJ, Jang JY, Shin A. 2018; Trends in gallbladder cancer incidence and survival in Korea. Cancer Res Treat. 50:1444–1451. DOI: 10.4143/crt.2017.279. PMID: 29370591. PMCID: PMC6192934.
5. Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J. 2002; Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: demographics, pathology and survival. ANZ J Surg. 72:857–861. DOI: 10.1046/j.1445-2197.2002.02589.x. PMID: 12485219.
6. Flemming JA, Zhang-Salomons J, Nanji S, Booth CM. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: a population-based study. Cancer. 2016; 122:2534–2543. DOI: 10.1002/cncr.30074. PMID: 27183133.
7. Cancer Research UK. 2015. Gallbladder cancer incidence statistics [Internet]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/gallbladder-cancer/incidence. cited 2021 Oct 10. London: Cancer Research UK.
8. Torre LA, Siegel RL, Islami F, Bray F, Jemal A. 2018; Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clin Gastroenterol Hepatol. 16:427–437. DOI: 10.1016/j.cgh.2017.08.017. PMID: 28826679.
9. Australian Institute of Health and Welfare. 2021. Australian Cancer Database (ACD) [Internet]. Available from: https://www.aihw.gov.au/about-our-data/our-data-collections/australian-cancer-database. cited 2021 Sep 27. Darlinghurst: Australian Institute of Health and Welfare.
10. Australian Institute of Health and Welfare. 2021. Cancer data in Australia [Internet]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/summary. cited 2021 Sep 25. Darlinghurst: Australian Institute of Health and Welfare.
11. Kim HJ, Fay MP, Feuer EJ, Midthune DN. 2000; Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 19:335–351. Erratum in: Stat Med 2001;20:655. DOI: 10.1002/sim.811. PMID: 10649300.
12. Hardy KJ. 2011; Laparoscopic cholecystectomy: Australian beginnings. ANZ J Surg. 81:866–870. DOI: 10.1111/j.1445-2197.2011.05898.x. PMID: 22507410.
13. Australian Institute of Health and Welfare. 2021. Procedures data cubes [Internet]. Available from: https://www.aihw.gov.au/reports/hospitals/procedures-data-cubes/contents/data-cubes. cited 2021 Oct 8. Darlinghurst: Australian Institute of Health and Welfare.
14. Hundal R, Shaffer EA. 2014; Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 6:99–109. DOI: 10.2147/CLEP.S37357. PMID: 24634588. PMCID: PMC3952897.
15. Diehl AK, Beral V. 1981; Cholecystectomy and changing mortality from gallbladder cancer. Lancet. 2:187–189. DOI: 10.1016/S0140-6736(81)90366-4. PMID: 6114251.
16. Serra I, Yamamoto M, Calvo A, Cavada G, Báez S, Endoh K, Watanabe H, Tajima K. 2002; Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer. 102:407–411. Erratum in: Int J Cancer 2003;104:798. DOI: 10.1002/ijc.10716. PMID: 12402311.
17. Lee MH, Gao YT, Huang YH, McGee EE, Lam T, Wang B, et al. 2020; A metallomic approach to assess associations of serum metal levels with gallstones and gallbladder cancer. Hepatology. 71:917–928. DOI: 10.1002/hep.30861. PMID: 31318976. PMCID: PMC6980252.
18. Randi G, Franceschi S, La Vecchia C. 2006; Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 118:1591–1602. DOI: 10.1002/ijc.21683. PMID: 16397865.
19. Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. 2019; Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 8:33. DOI: 10.21037/cco.2019.08.03. PMID: 31484488.
20. Rawla P, Sunkara T, Thandra KC, Barsouk A. 2019; Epidemiology of gallbladder cancer. Clin Exp Hepatol. 5:93–102. DOI: 10.5114/ceh.2019.85166. PMID: 31501784. PMCID: PMC6728871.
21. Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellöf L. 1989; Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol. 18:50–54. DOI: 10.1093/ije/18.1.50. PMID: 2722383.
22. Australian Institute of Health and Welfare. 2020. Overweight and obesity [Internet]. Available from: https://www.aihw.gov.au/reports/australias-health/overweight-and-obesity. cited 2021 Oct 2. Darlinghurst: Australian Institute of Health and Welfare.
23. Australian Bureau of Statistics. 2018. Estimates of Aboriginal and Torres Strait Islander Australians [Internet]. Available from: https://www.abs.gov.au/statistics/people/aboriginal-and-torres-strait-islander-peoples/estimates-aboriginal-and-torres-strait-islander-australians/latest-release. cited 2021 Oct 3. Belconnen: Australian Bureau of Statistics.
24. Zhang X, Condon J, Dempsey K, Garling L. Cancer in the Northern Territory 1991-2010: incidence, mortality and survival. Darwin: Department of Health;2014. DOI: 10.1093/ije/18.1.50.
25. Wigg AJ, Narayana SK, Hartel G, Medlin L, Pratt G, Powell EE, et al. 2021; Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia. EClinicalMedicine. 36:100919. DOI: 10.1016/j.eclinm.2021.100919. PMID: 34142069. PMCID: PMC8187829.
26. Kamiza AB, Su FH, Wang WC, Sung FC, Chang SN, Yeh CC. 2016; Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer. 16:861. DOI: 10.1186/s12885-016-2918-5. PMID: 27821099. PMCID: PMC5100218.
27. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, et al. 2008; Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer. 122:1849–1853. DOI: 10.1002/ijc.23251. PMID: 18076042.
28. DiGiacomo M, Davidson PM, McGrath SJ, Dharmendra T, Thompson SC. 2012. Cancer in aboriginal and torres strait islander peoples: a rapid review of the literature. Sydney: UTS ePress;DOI: 10.1002/ijc.23251.
29. Wietsma MFT, Molloy C, Bhimani N, de Savornin Lohman EAJ, Gill AJ, Andrici J, et al. 2021; Gallbladder carcinoma outcomes in an Australian tertiary referral hospital. ANZ J Surg. 91:603–608. DOI: 10.1111/ans.16663. PMID: 33604992.
30. Cocker F, Chien Yee K, Palmer AJ, de Graaff B. 2019; Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide. Aust N Z J Public Health. 43:267–273. DOI: 10.1111/1753-6405.12889. PMID: 30958629.
31. Wallace MC, Preen DB, Short MW, Adams LA, Jeffrey GP. Hepatocellular carcinoma in Australia 1982-2014: increasing incidence and improving survival. Liver Int. 2019; 39:522–530. DOI: 10.1111/liv.13966. PMID: 30230194.
32. Young JP, Win AK, Rosty C, Flight I, Roder D, Young GP, et al. 2015; Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol. 30:6–13. DOI: 10.1111/jgh.12792. PMID: 25251195.
33. Mikaeel RR, Young JP, Hardingham JE, Tapia Rico G, Hewett PJ, Symonds EL, et al. 2021; Appendiceal neoplasm incidence and mortality rates are on the rise in Australia. Expert Rev Gastroenterol Hepatol. 15:203–210. DOI: 10.1080/17474124.2021.1832467. PMID: 33022181.
Full Text Links
  • AHBPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr